BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 34242567)

  • 1. The interaction of disulfiram and H
    Read E; Milford J; Zhu J; Wu L; Bilodeau M; Yang G
    Toxicol Appl Pharmacol; 2021 Sep; 426():115642. PubMed ID: 34242567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of cystathionine-β-synthase inhibition by disulfiram: The role of bis(N,N-diethyldithiocarbamate)-copper(II).
    Zuhra K; Panagaki T; Randi EB; Augsburger F; Blondel M; Friocourt G; Herault Y; Szabo C
    Biochem Pharmacol; 2020 Dec; 182():114267. PubMed ID: 33035509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disulfiram's anti-cancer activity reflects targeting NPL4, not inhibition of aldehyde dehydrogenase.
    Skrott Z; Majera D; Gursky J; Buchtova T; Hajduch M; Mistrik M; Bartek J
    Oncogene; 2019 Oct; 38(40):6711-6722. PubMed ID: 31391554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disulfiram modulates stemness and metabolism of brain tumor initiating cells in atypical teratoid/rhabdoid tumors.
    Choi SA; Choi JW; Wang KC; Phi JH; Lee JY; Park KD; Eum D; Park SH; Kim IH; Kim SK
    Neuro Oncol; 2015 Jun; 17(6):810-21. PubMed ID: 25378634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disulfiram, an alcohol dependence therapy, can inhibit the in vitro growth of Francisella tularensis.
    Hamblin KA; Flick-Smith H; Barnes KB; Pereira-Leal JB; Surkont J; Hampson R; Atkins HS; Harding SV
    Int J Antimicrob Agents; 2019 Jul; 54(1):85-88. PubMed ID: 31029736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivation of Aldehyde Dehydrogenase by Disulfiram in the Presence and Absence of Lipoic Acid or Dihydrolipoic Acid: An in Vitro Study.
    Bilska-Wilkosz A; Górny M; Iciek M
    Biomolecules; 2019 Aug; 9(8):. PubMed ID: 31426424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two clinical drugs deubiquitinase inhibitor auranofin and aldehyde dehydrogenase inhibitor disulfiram trigger synergistic anti-tumor effects in vitro and in vivo.
    Huang H; Liao Y; Liu N; Hua X; Cai J; Yang C; Long H; Zhao C; Chen X; Lan X; Zang D; Wu J; Li X; Shi X; Wang X; Liu J
    Oncotarget; 2016 Jan; 7(3):2796-808. PubMed ID: 26625200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting ALDH1A1 by disulfiram/copper complex inhibits non-small cell lung cancer recurrence driven by ALDH-positive cancer stem cells.
    Liu X; Wang L; Cui W; Yuan X; Lin L; Cao Q; Wang N; Li Y; Guo W; Zhang X; Wu C; Yang J
    Oncotarget; 2016 Sep; 7(36):58516-58530. PubMed ID: 27542268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disulfiram modulates ROS accumulation and overcomes synergistically cisplatin resistance in breast cancer cell lines.
    Yang Z; Guo F; Albers AE; Sehouli J; Kaufmann AM
    Biomed Pharmacother; 2019 May; 113():108727. PubMed ID: 30870721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disulfiram targets cancer stem-like properties and the HER2/Akt signaling pathway in HER2-positive breast cancer.
    Kim JY; Cho Y; Oh E; Lee N; An H; Sung D; Cho TM; Seo JH
    Cancer Lett; 2016 Aug; 379(1):39-48. PubMed ID: 27238567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effect on ovarian cancer ALDH+ stem-like cells by Disulfiram and Copper treatment through ALDH and ROS modulation.
    Guo F; Yang Z; Kulbe H; Albers AE; Sehouli J; Kaufmann AM
    Biomed Pharmacother; 2019 Oct; 118():109371. PubMed ID: 31545281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disulfiram overcomes bortezomib and cytarabine resistance in Down-syndrome-associated acute myeloid leukemia cells.
    Bista R; Lee DW; Pepper OB; Azorsa DO; Arceci RJ; Aleem E
    J Exp Clin Cancer Res; 2017 Feb; 36(1):22. PubMed ID: 28143565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disulfiram's Anticancer Activity: Evidence and Mechanisms.
    Jiao Y; Hannafon BN; Ding WQ
    Anticancer Agents Med Chem; 2016; 16(11):1378-1384. PubMed ID: 27141876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-hepatocellular carcinoma properties of the anti-alcoholism drug disulfiram discovered to enzymatically inhibit the AMPK-related kinase SNARK in vitro.
    Goto K; Kato N; Chung RT
    Oncotarget; 2016 Nov; 7(46):74987-74999. PubMed ID: 27602492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S-methyl-N,N-diethylthiocarbamate sulfoxide and S-methyl-N,N-diethylthiocarbamate sulfone, two candidates for the active metabolite of disulfiram.
    Mays DC; Nelson AN; Lam-Holt J; Fauq AH; Lipsky JJ
    Alcohol Clin Exp Res; 1996 May; 20(3):595-600. PubMed ID: 8727261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential Cytotoxicity Mechanisms of Copper Complexed with Disulfiram in Oral Cancer Cells.
    Chen SY; Chang YL; Liu ST; Chen GS; Lee SP; Huang SM
    Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33918312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo inhibition of aldehyde dehydrogenase by disulfiram.
    Lipsky JJ; Shen ML; Naylor S
    Chem Biol Interact; 2001 Jan; 130-132(1-3):93-102. PubMed ID: 11306034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disulfiram Acts as a Potent Radio-Chemo Sensitizer in Head and Neck Squamous Cell Carcinoma Cell Lines and Transplanted Xenografts.
    Yao W; Qian X; Ochsenreither S; Soldano F; DeLeo AB; Sudhoff H; Oppel F; Kuppig A; Klinghammer K; Kaufmann AM; Albers AE
    Cells; 2021 Feb; 10(3):. PubMed ID: 33671083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in the kinetic properties and sensitivity to inhibitors of human placental, erythrocyte, and major hepatic aldehyde dehydrogenase isoenzymes.
    Zorzano A; Herrera E
    Biochem Pharmacol; 1990 Mar; 39(5):873-8. PubMed ID: 2310412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disulfiram/copper targets stem cell-like ALDH
    Jin N; Zhu X; Cheng F; Zhang L
    J Cell Biochem; 2018 Aug; 119(8):6882-6893. PubMed ID: 29665144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.